Takeda Sweetens Offer for Shire: Deal – You Win! No-Deal – You Win Too!
Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 20, 2018 proposal of ÂŁ47 / share (~$197.4 / ADS), valuing Shire PLC (SHP LN)Â at ~$60b, is...
328 Views
Shire Remains Undervalued as Takeda Weighs Higher Bid and Allergan Enters the Picture
Shire PLC (SHP LN) has released details of recent negotiations with Takeda Pharmaceutical Co Ltd (4502 JP), detailing three proposed (and rejected)...
315 Views
Takeda + Shire - Monetizing Shire’s Neuroscience Division Could Be the Key
CEO Christopher Weber has always been vocal about his willingness to strike a multi-billion-dollar deal, if need be, to put in place Takeda’s...
334 Views
Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings
Announcement – Takeda, on March 28, 2018, confirmed that it is officially considering making an offer for Shire (NASDAQ: SHPG) and that it has time...
423 Views
Takeda Considers Swallowing Shire, a Somewhat Surprising Move That Could Make Strategic Sense
Japanese pharma firm Takeda Pharmaceutical Co Ltd (4502 JP) said it is officially considering making an offer for diversified rare-disease-focused...
324 Views